- Home
- COLD vs LEGN Comparison
COLD vs LEGN Comparison
Compare COLD & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLD
- LEGN
- Stock Information
- Founded
- COLD 1903
- LEGN 2014
- Country
- COLD United States
- LEGN United States
- Employees
- COLD N/A
- LEGN N/A
- Industry
- COLD Real Estate Investment Trusts
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- COLD Real Estate
- LEGN Health Care
- Exchange
- COLD Nasdaq
- LEGN Nasdaq
- Market Cap
- COLD 4.8B
- LEGN 5.4B
- IPO Year
- COLD 2018
- LEGN 2020
- Fundamental
- Price
- COLD $15.72
- LEGN $38.80
- Analyst Decision
- COLD Buy
- LEGN Strong Buy
- Analyst Count
- COLD 12
- LEGN 11
- Target Price
- COLD $24.50
- LEGN $74.60
- AVG Volume (30 Days)
- COLD 3.0M
- LEGN 1.4M
- Earning Date
- COLD 08-07-2025
- LEGN 08-11-2025
- Dividend Yield
- COLD 5.86%
- LEGN N/A
- EPS Growth
- COLD N/A
- LEGN N/A
- EPS
- COLD N/A
- LEGN N/A
- Revenue
- COLD $2,626,425,000.00
- LEGN $728,303,000.00
- Revenue This Year
- COLD $1.25
- LEGN $65.33
- Revenue Next Year
- COLD $5.04
- LEGN $54.68
- P/E Ratio
- COLD N/A
- LEGN N/A
- Revenue Growth
- COLD N/A
- LEGN 112.46
- 52 Week Low
- COLD $15.45
- LEGN $27.34
- 52 Week High
- COLD $30.45
- LEGN $59.62
- Technical
- Relative Strength Index (RSI)
- COLD 37.80
- LEGN 47.38
- Support Level
- COLD $16.08
- LEGN $38.53
- Resistance Level
- COLD $17.12
- LEGN $45.30
- Average True Range (ATR)
- COLD 0.44
- LEGN 1.76
- MACD
- COLD -0.04
- LEGN -0.61
- Stochastic Oscillator
- COLD 15.87
- LEGN 9.73
About COLD Americold Realty Trust Inc.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.